AFT Pharmaceuticals Future Growth
Future criteria checks 3/6
AFT Pharmaceuticals is forecast to grow earnings and revenue by 19.3% and 13% per annum respectively. EPS is expected to grow by 14.3% per annum. Return on equity is forecast to be 19.3% in 3 years.
Key information
19.3%
Earnings growth rate
14.3%
EPS growth rate
| Pharmaceuticals earnings growth | 27.7% |
| Revenue growth rate | 13.0% |
| Future return on equity | 19.3% |
| Analyst coverage | Low |
| Last updated | 05 Mar 2024 |
Recent future growth updates
Recent updates
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?
May 22
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?
Oct 17Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?
May 23Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?
Dec 01We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise
Jul 30With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For
Jun 02Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?
Mar 20A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation
Feb 13
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 23Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?
Jan 02Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?
Dec 12AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 311 | 24 | 34 | N/A | 1 |
| 3/31/2026 | 257 | 24 | 23 | 17 | 3 |
| 3/31/2025 | 220 | 17 | 8 | 12 | 3 |
| 3/31/2024 | 193 | 15 | 8 | 14 | 3 |
| 9/30/2023 | 175 | 11 | 4 | 13 | N/A |
| 6/30/2023 | 166 | 11 | 3 | 12 | N/A |
| 3/31/2023 | 157 | 11 | 2 | 12 | N/A |
| 12/31/2022 | 149 | 14 | 4 | 12 | N/A |
| 9/30/2022 | 141 | 17 | 6 | 13 | N/A |
| 6/30/2022 | 135 | 18 | 7 | 14 | N/A |
| 3/31/2022 | 130 | 20 | 9 | 14 | N/A |
| 12/31/2021 | 125 | 15 | 7 | 12 | N/A |
| 9/30/2021 | 120 | 11 | 5 | 10 | N/A |
| 6/30/2021 | 116 | 9 | 0 | 6 | N/A |
| 3/31/2021 | 113 | 8 | -5 | 1 | N/A |
| 12/31/2020 | 110 | 5 | -4 | 3 | N/A |
| 9/30/2020 | 107 | 3 | -2 | 6 | N/A |
| 6/30/2020 | 107 | 7 | 3 | 10 | N/A |
| 3/31/2020 | 106 | 12 | 8 | 15 | N/A |
| 12/31/2019 | 100 | 11 | 7 | 12 | N/A |
| 9/30/2019 | 94 | 11 | 5 | 9 | N/A |
| 6/30/2019 | 89 | 4 | 1 | 5 | N/A |
| 3/31/2019 | 85 | -3 | -2 | 1 | N/A |
| 12/31/2018 | 84 | -7 | -5 | -1 | N/A |
| 9/30/2018 | 83 | -11 | -8 | -4 | N/A |
| 6/30/2018 | 82 | -12 | -10 | -6 | N/A |
| 3/31/2018 | 81 | -14 | -12 | -9 | N/A |
| 12/31/2017 | 79 | -14 | -15 | -13 | N/A |
| 9/30/2017 | 76 | -14 | -17 | -16 | N/A |
| 6/30/2017 | 73 | -16 | N/A | -18 | N/A |
| 3/31/2017 | 69 | -18 | N/A | -19 | N/A |
| 12/31/2016 | 67 | -18 | N/A | -20 | N/A |
| 9/30/2016 | 64 | -18 | N/A | -21 | N/A |
| 6/30/2016 | 64 | -16 | N/A | -17 | N/A |
| 3/31/2016 | 64 | -13 | N/A | -14 | N/A |
| 12/31/2015 | 63 | -13 | N/A | -12 | N/A |
| 9/30/2015 | 62 | -13 | N/A | -10 | N/A |
| 6/30/2015 | 59 | -13 | N/A | -11 | N/A |
| 3/31/2015 | 56 | -13 | N/A | -13 | N/A |
| 3/31/2014 | 49 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AFT's forecast earnings growth (19.3% per year) is above the savings rate (2.6%).
Earnings vs Market: AFT's earnings (19.3% per year) are forecast to grow faster than the NZ market (17.6% per year).
High Growth Earnings: AFT's earnings are forecast to grow, but not significantly.
Revenue vs Market: AFT's revenue (13% per year) is forecast to grow faster than the NZ market (5.3% per year).
High Growth Revenue: AFT's revenue (13% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AFT's Return on Equity is forecast to be low in 3 years time (19.3%).